Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-06
2010-06-01
Krass, Frederick (Department: 1612)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07728148
ABSTRACT:
The present invention discloses compounds of formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof:which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
REFERENCES:
patent: 6323180 (2001-11-01), Linas-Brunet et al.
patent: 6995174 (2006-02-01), Wang et al.
patent: 7132504 (2006-11-01), Scola et al.
patent: 7135462 (2006-11-01), Scola et al.
patent: 7273851 (2007-09-01), Miao et al.
Dorwald F. A. (Side reactions in organic synthesis, 2005, Wiley, VCH, Weinheim, p. IX of Preface).
Herr, J. R.,A Whirlwind Tour of Current Mitsunobu Chemistry. Albany Molecular Research, Inc. Technical report, 1999, vol. 3, No. 19, 1999, pp. 1-36 (particularly pp. 11-12).
U.S. Appl. No. 11/759,080, filed Jun. 6, 2007, Sun et al.
Or Yat Sun
Sun Ying
Wang Zhe
Elmore Carolyn S.
Elmore Patent Law Group P.C.
Enanta Pharmaceuticals, Inc.
Issac Roy P.
Krass Frederick
LandOfFree
Acyclic oximyl hepatitis C protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyclic oximyl hepatitis C protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyclic oximyl hepatitis C protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4249205